Attached files
| file | filename |
|---|---|
| 10-Q - NURX PHARMACEUTICALS, INC. | v174462_10q.htm |
| EX-31.2 - NURX PHARMACEUTICALS, INC. | v174462_ex31-2.htm |
| EX-31.1 - NURX PHARMACEUTICALS, INC. | v174462_ex31-1.htm |
EXHIBIT
32.1
CERTIFICATIONS
OF THE CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
PURSUANT
TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In
connection with the filing of the Quarterly Report on Form 10-Q for the period
ended December 31, 2009 (the “Report”) by NuRx Pharmaceuticals, Inc.
(“Registrant”), each of the undersigned hereby certifies that, to his
knowledge:
1. The
Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934, as amended; and
2. The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of Registrant as of and for
the periods presented in the Report.
|
Date:
February 16 , 2010
|
/s/
Harin Padma-Nathan
|
|
Harin
Padma-Nathan, Chief Executive Officer
|
|
|
(Principal
Executive Officer)
|
|
|
/s/
Steven Gershick
|
|
|
Steven
Gershick, Chief Financial Officer
|
|
|
(Principal
Financial and Accounting
Officer)
|